In order to access this content you must be logged in and have a subscription to PL Intelligence.

PL Intelligence is a one-stop environment for time-conscious executives. Keeping you abreast of the latest developments in the life sciences industry, saving you time and money when you need it most.
Progen to manufacture anti-cancer compound for Peplin
Cell Pathways receives patent for the anti-cancer drug
PROGEN COMMENCES NEGOTIATIONS FOR GLOBAL LICENSING OF PI-88
Aphton granted anti- GnRH patent
Diversa expands patent protection of drug screening technologies
Access Pharmaceuticals issued US Patent for anti-cancer compound
Microcide and coelacanth sign anti-infectives deal
Prima receives Australian Patent for Methods of Treating Cancer with Antibodies